Top Marijuana Shares in the NASDAQ

Top Marijuana Shares in the NASDAQ

Even though the greater part of U.S.-based cannabis organizations and lots of foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), several marijuana businesses are exchanged from the NASDAQ. Some investors choose shares which can be noted on the NASDAQ to many other exchanges because of their increased liquidity and tighter spreads set alongside the markets that are over-the-counter. As an example, since the cannabis industry has exploded in current months and years, uplisting from an OTC market to an established U.S. trade is becoming a advertising achievement for most marijuana that is rising. (For related reading, see “Understanding Medical Cannabis vs. Recreational Cannabis shares”)

An number that is increasing of businesses are increasingly being noted on reputable U.S. exchanges instead of being exchanged regarding the OTC market showing the fast development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ ended up being initial exchange that is electronic is certainly synonymous with technology and biotechnology. The cannabis businesses in the NASDAQ mirror this, while the majority of them run within the biotech area of this industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical purchase, at the time of October 26, 2019, with a failure of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is just a biotech business mixed up in production of medical marijuana medications. Research and development around Arena’s APD371 could be the focus that is primary of firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is a check this is certainly blank that is in a merger contract with Kalyx developing Inc. Kalyx is a respected owning a home rely upon the regulated cannabis industry in the usa.

Key Takeaways

  • The cannabis industry, especially the part of cannabis and biotech, is attracting investor attention that is substantial.
  • Cannabis has been found in brand brand new drugs for the treating pain and chronic that is many inflammatory, and fibrotic conditions.
  • Organizations are also developing cannabinoid items for autism range disorders, schizophrenia, glioma, Tourette syndrome, epileptic problems, Prader-Willi Syndrome (a hereditary condition), and amphetamine addiction.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is just a clinical-stage biotechnology company focused on developing and commercializing chemical that is new for the indications of discomfort and pruritus (itching). Although all the company’s clinical-stage items target opioid receptors, Cara happens to be conducting preclinical research on cannabinoids to treat neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech company. The team’s research, development, and production are based around cannabis drugs that look for to deal with chronic, inflammatory, fibrotic, along with other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is just a cannabis that are canadian. The team has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced intends to invest $1.8 billion in Cronos. The investment has provided Cronos not just with additional money to invest in its continued expansion but in addition having a partner that is well-established within the marketing of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis usage add-ons and vaporization gear and items to retail customers in the U.S. and Canada. Furthermore, it operates websites that are e-commerce additional product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is having a profile of cannabinoid medications. These medications consist of Sativex for the treatment of spasticity associated with multiple sclerosis and cancer tumors discomfort and Epidiolex to treat youth epilepsy. Sativex is commercialized much more than the usual dozen nations away from united states of america and contains received approval that is regulatory several other nations. Epidiolex received Food And Drug Administration approval as being a treatment plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of serious, early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing cannabinoid items for autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is really a clinical-stage biopharmaceutical business that is developing medications centered on its proprietary Accordion Pill technology. Intec’s product pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based pest administration and plant health services and products. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now appropriate for usage on cannabis plants into the California cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern Beverages Corp. is really a maker of beverages produced from yerba mate, green tea extract, kombucha, and comparable items. In recent months, modern age has expanded its beverage offerings to add CBD infusions also, bringing it to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in might of 2019, rendering it probably one of the most current cannabis organizations to record in reviews the exchange that is popular. The business happens to be quickly expanding its manufacturing ability that can have the ability to produce up to 113,000 kilograms of product per 12 months by the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation operates when you look at the enforcement sector. The company’s business operations support medication evaluation through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is another entry that is new the NASDAQ exchange. The cannabis producer made headlines in October of 2019 (and saw a brief cost boost) when it announced the production of a brand new Palmetto model of leisure cannabis, first available in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is really a specialty clinical-stage pharmaceutical business concentrated regarding the growth of cannabinoid-based medications. Therapix’s current pipeline includes items targeted to treat Tourette problem and mild cognitive impairment.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being the initial company that is marijuana-related have a short public providing (IPO) in america. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis services and products.

Village Farms Global (NASDAQ:VFF)

Village Farms Overseas is one of cannabis that are recent to begin investing on the NASDAQ. The business’s stocks became designed for trade on February 21, 2019. The organization features a history that is decades-long greenhouse produce manufacturing and it has just recently shifted several of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted in the growth of synthetic treatments that are cannabinoid transdermal (through your skin) delivery. Their pipeline presently includes two medications being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.

Leave a Reply

Your email address will not be published. Required fields are marked *